Kiromic Biopharma News

KRBPDelisted Stock  USD 2.68  0.07  2.55%   
Slightly above 62% of Kiromic Biopharma's investor base is looking to short. The analysis of overall sentiment of trading Kiromic Biopharma stock suggests that many investors are alarmed at this time. Kiromic Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Kiromic Biopharma. Many technical investors use Kiromic Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at news.google.com         
Should You Hold Kiromic Biopharma Inc Stock Monday - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Is it Time to Dump Kiromic Biopharma Inc Stock After it Is Higher By 7.24 percent in a Week - Invest...
Google News at Macroaxis
over a year ago at businesswire.com         
Kiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for N...
businesswire News
over a year ago at thelincolnianonline.com         
Kiromic BioPharma, Inc. Short Interest Update
news
over a year ago at news.google.com         
Will Kiromic Biopharma Inc Stay at the Bottom of the Healthcare Sector - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Healthcare Stocks on the Move Wednesday THMO, MLEC, ELEV, JNCE, EUDA, SY, KRBP, ONCS - InvestorsObse...
Google News at Macroaxis
over a year ago at news.google.com         
Kiromic Biopharma Inc Stock Climbs 15.38 percent This Week Should You Buy - InvestorsObserver
Google News at Macroaxis
over a year ago at benzinga.com         
Bluegreen Vacations, Eagle Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
benzinga news
over a year ago at thelincolnianonline.com         
Kiromic BioPharma, Inc. Short Interest Up 110.9 percent in February
news
over a year ago at businesswire.com         
Kiromic BioPharma Announces Reverse Stock Split
businesswire News
over a year ago at news.google.com         
What is the Markets View on Kiromic Biopharma Inc Stocks Price and Volume Trends Thursday - Investor...
Google News at Macroaxis
over a year ago at news.google.com         
Is Kiromic Biopharma Inc Stock at the Top of the Biotechnology Industry - InvestorsObserver
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Kiromic BioPharma Reports Favorable Deltacel Preclinical Pharmacology Results
Yahoo News
over a year ago at businesswire.com         
Kiromic BioPharma Reports Favorable Deltacel Preclinical Pharmacology Results
businesswire News
over a year ago at businesswire.com         
Kiromic BioPharma Reports Favorable Deltacel Preclinical Pharmacology Results
businesswire News
Far too much social signal, news, headlines, and media speculation about Kiromic Biopharma that are available to investors today. That information is available publicly through Kiromic media outlets and privately through word of mouth or via Kiromic internal channels. However, regardless of the origin, that massive amount of Kiromic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kiromic Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kiromic Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kiromic Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kiromic Biopharma alpha.

Kiromic Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Kiromic BioPharma, Inc. Sees Large Increase in Short Interest
05/03/2023
2
Should You Hold Kiromic Biopharma Inc Stock Tuesday Morning - InvestorsObserver
05/16/2023
3
Kiromic Biopharma Shares Down 12 percent After Stock Offering Prospectus
06/30/2023
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in Kiromic Stock

If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios